BIO-TECHNE Corp

BIO-TECHNE Corp develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company's product portfolio and application expertise support scientific investigations into biological processes and molecular diagnostics, helping to understand the nature, diagnosis, causes, and progression of specific diseases. Its products assist in drug discovery and provide tools for accurate clinical tests and diagnoses. BIO-TECHNE manages its business through two operating segments: Protein Sciences and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures high-quality biological reagents used in life science research, diagnostics, and cell and gene therapy. This segment also offers proteomic analytical tools, both manual and automated, for protein analysis, automated western blot, and multiplexed ELISA workflows. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market. It also provides advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis, as well as genetic and oncology kits for research and clinical applications. BIO-TECHNE is a Minnesota corporation with its global headquarters in Minneapolis, Minnesota. Founded in 1976 as Research and Diagnostic Systems, Inc., it became a publicly traded company in 1985 through a merger with Techne Corporation, now Bio-Techne Corporation. Its common stock is listed on the NASDAQ under the symbol "TECH." The company operates globally, with offices in North America, Europe, and Asia. Its product lines include hundreds of thousands of diverse products, most of which are manufactured in multiple locations in North America, the U.K., Canada, Switzerland, and China.